RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few BPC 157 and Regenerative Peptides: What Actually Matters